Home/Filings/4/0000899243-21-044381
4//SEC Filing

Azad Babak 4

Accession 0000899243-21-044381

CIK 0001809519other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:44 PM ET

Size

11.4 KB

Accession

0000899243-21-044381

Insider Transaction Report

Form 4
Period: 2021-11-09
Azad Babak
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-11-0912,500292,500 total
    Exercise: $5.94Exp: 2030-01-30Class A Common Stock (12,500 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2021-11-09$5.94/sh+12,500$74,25012,500 total
  • Sale

    Class A Common Stock

    2021-11-09$43.13/sh800$34,5000 total
  • Sale

    Class A Common Stock

    2021-11-09$42.17/sh11,700$493,341800 total
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of December 9, 2020, as amended September 2, 2021.
  • [F2]This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.76 to $42.63. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.82 to $43.55. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019.

Issuer

GoodRx Holdings, Inc.

CIK 0001809519

Entity typeother

Related Parties

1
  • filerCIK 0001822193

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:44 PM ET
Size
11.4 KB